Australia markets close in 1 hour 4 minutes

Exopharm Limited (EX1.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0900-0.0010 (-1.10%)
As of 11:02AM AEDT. Market open.
Currency in AUD

Valuation measures4

Market cap (intra-day) 14.15M
Enterprise value 13.05M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)141.86
Price/book (mrq)1.61
Enterprise value/revenue 130.81
Enterprise value/EBITDA -1.58

Trading information

Stock price history

Beta (5Y monthly) 1.29
52-week change 3-79.32%
S&P500 52-week change 3-12.31%
52-week high 30.5350
52-week low 30.0810
50-day moving average 30.1093
200-day moving average 30.1722

Share statistics

Avg vol (3-month) 3112.73k
Avg vol (10-day) 352.94k
Shares outstanding 5157.21M
Implied shares outstanding 6N/A
Float 890.73M
% held by insiders 144.26%
% held by institutions 10.55%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 June 2022
Most-recent quarter (mrq)30 June 2022


Profit margin -239.73%
Operating margin (ttm)-237.87%

Management effectiveness

Return on assets (ttm)-35.66%
Return on equity (ttm)-72.88%

Income statement

Revenue (ttm)4.21M
Revenue per share (ttm)0.03
Quarterly revenue growth (yoy)0.30%
Gross profit (ttm)15.63k
Net income avi to common (ttm)-10.08M
Diluted EPS (ttm)-0.0670
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)4.85M
Total cash per share (mrq)0.03
Total debt (mrq)3.74M
Total debt/equity (mrq)42.49
Current ratio (mrq)2.12
Book value per share (mrq)0.06

Cash flow statement

Operating cash flow (ttm)-8.53M
Levered free cash flow (ttm)-6M